We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$297B
AUM Growth
+$53.1B
Cap. Flow
+$26.9B
Cap. Flow %
9.06%
Top 10 Hldgs %
35.93%
Holding
10,215
New
1,302
Increased
3,894
Reduced
3,315
Closed
1,631

Sector Composition

Rank Sector Weight
1 Technology 3.96%
2 Consumer Discretionary 3.1%
3 Financials 1.5%
4 Healthcare 1.15%
5 Communication Services 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AREC icon
8151
American Resources Corp
AREC
$272M
$42.8K ﹤0.01%
+21,836
New +$33.3K
WKHS icon
8152
CALL
Workhorse Group
WKHS
$37.3M
$42.6K ﹤0.01%
16
+3
+23% +$8.66K
AMRN
8153
Amarin Corp
AMRN
$304M
$42.4K ﹤0.01%
1,783
+317
+22% +$8.14K
CRMD icon
8154
PUT
CorMedix
CRMD
$586M
$42.4K ﹤0.01%
+10,700
New +$52.9K
BNGO icon
8155
Bionano Genomics
BNGO
$12.7M
$42.2K ﹤0.01%
115
-142
-55% -$64.1K
ERAS icon
8156
Erasca
ERAS
$6.27B
$42.1K ﹤0.01%
15,249
-265,315
-95% -$756K
OMIC
8157
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$41.8K ﹤0.01%
+1,678
New +$49.2K
ROSS.WS
8158
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$41.3K ﹤0.01%
244,176
-269
-0.1% -$67
CMRX
8159
DELISTED
Chimerix, Inc.
CMRX
$41.2K ﹤0.01%
+34,074
New +$43.2K
OTLK icon
8160
Outlook Therapeutics
OTLK
$183M
$41.1K ﹤0.01%
+1,182
New +$32.2K
ALYA
8161
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$41K ﹤0.01%
+25,175
New +$46.5K
IPM
8162
Intelligent Protection Management Corp
IPM
$23.9M
$40.8K ﹤0.01%
21,824
-17,383
-44% -$40.5K
HYPR icon
8163
Hyperfine
HYPR
$97.3M
$40.6K ﹤0.01%
18,899
-7,924
-30% -$12.9K
CNSL
8164
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$40.4K ﹤0.01%
+10,560
New +$38.1K
VBIV
8165
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$40.1K ﹤0.01%
12,191
+11,469
+1,589% +$34.7K
EGY icon
8166
Vaalco Energy
EGY
$607M
$39.8K ﹤0.01%
10,577
-104,756
-91% -$428K
DCFC
8167
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$39.7K ﹤0.01%
182
-494
-73% -$107K
PYR
8168
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$39.4K ﹤0.01%
57,357
-7,800
-12% -$5.84K
AISPW
8169
Airship AI Holdings Warrants
AISPW
$14.4M
$39.1K ﹤0.01%
222,027
-376,077
-63% -$38.7K
NBSTW
8170
DELISTED
Newbury Street Acquisition Corporation Warrants
NBSTW
$39K ﹤0.01%
205,147
-397
-0.2% -$68
SMMT icon
8171
CALL
Summit Therapeutics
SMMT
$11B
$38.9K ﹤0.01%
15,500
-30,500
-66% -$55.7K
MSPRZ
8172
DELISTED
MSP Recovery Inc Warrant
MSPRZ
$38.7K ﹤0.01%
90,000
-1,572
-2% -$906
SDC
8173
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$38.6K ﹤0.01%
72,744
-6,648
-8% -$2.71K
GORO icon
8174
Goldgroup Mining Inc.
GORO
$187M
$38.4K ﹤0.01%
60,896
-575,792
-90% -$510K
FAX
8175
abrdn Asia-Pacific Income Fund
FAX
$594M
$38.2K ﹤0.01%
2,361
-502
-18% -$8.15K

Similar funds

Jane Street's Q2 2023 Portfolio in Review

As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.

By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.

  • Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
  • Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
  • Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
  • Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
  • Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
  • Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
  • Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.